Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
Brima Musa YounisAhmed Mudawi MusaSéverine MonneratMohammed Abdelrahim SaeedEltahir Awad Gasim KhalilAnas Elbashir AhmedMujahid Ahmed AliAli NoureldinGina Muthoni OuattaraGodfrey M NyakayaSamuel TeshomeTruphosa OmolloMichael OchiengThaddaeus EgondiMildred MmboneWan-Yu ChuThomas P C DorloEduard E ZijlstraMonique WasunnaJorge AlvarFabiana AlvesPublished in: PLoS neglected tropical diseases (2023)
ClinicalTrials.gov NCT03399955, https://clinicaltrials.gov/study/NCT03399955 ClinicalTrials.gov ClinicalTrials.gov.